Literature DB >> 2873174

A 2-year survey of Branhamella catarrhalis in a general hospital.

J M Smith, B M Lockwood.   

Abstract

During a 2-year period, 143 strains of Branhamella catarrhalis were recovered from 7929 respiratory tract specimens (mainly sputa) sent for routine microbiological investigations at a 500 bed general hospital. The incidence of beta-lactamase positive strains increased from 2.7% in 1983 to 40% of isolates in the last 5 months of 1984; this increase continued in the early months of 1985. Forty-four strains of Bran. catarrhalis recovered from 35 patients were considered on laboratory generated data potentially pathologically significant. Almost half of the beta-lactamase producing strains were recovered from these 35 patients. Clinical information from 21 of these patients revealed the isolates in all cases to be associated with the advent of a respiratory tract infection. Appropriate antibiotic therapy in 16 of the 21 patients resulted in clinical improvement although in only 11 of these was Bran. catarrhalis specifically considered the causative pathogen. Underlying lung pathology seemed a major factor in permitting Bran. catarrhalis to express its pathogenic potential.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873174     DOI: 10.1016/0195-6701(86)90078-2

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  The macrophage response to bacteria. Modulation of macrophage functional activity by peptidoglycan from Moraxella (Branhamella) catarrhalis.

Authors:  R Keller; J E Gustafson; R Keist
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia.

Authors:  C DiGiovanni; T V Riley; G F Hoyne; R Yeo; P Cooksey
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

Review 3.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 4.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 5.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

Review 6.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

7.  Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains.

Authors:  J S Fomsgaard; A Fomsgaard; N Høiby; B Bruun; C Galanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M van den Abeele
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.